|
Delayed
NYSE
12:38:26 01/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.160 USD | +1.75% |
|
-1.69% | -14.71% |
| 15/08 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 15/08 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.44% | -1.69% | +13.73% | +18.37% | -14.71% | -27.50% | -79.29% | -86.91% | -97.14% | 3.58Cr | |
| +4.16% | -0.30% | +6.32% | +32.63% | +84.62% | +58.96% | +94.17% | +11.49% | - | 7.15TCr | |
| -0.19% | +1.32% | -3.29% | +4.36% | +18.14% | +37.20% | +81.33% | +226.32% | +5,434.64% | 6.01TCr | |
| -1.51% | +2.39% | -0.24% | +5.39% | +6.95% | +9.10% | +36.79% | -18.02% | +209.91% | 4.89TCr | |
| -0.05% | +0.70% | +3.27% | +39.60% | +19.66% | +42.01% | +39.12% | +12.60% | +232.75% | 4.43TCr | |
| +1.00% | +8.65% | +0.81% | +10.66% | +160.19% | +343.78% | +691.92% | +653.34% | - | 4.38TCr | |
| +0.45% | +1.05% | +2.58% | +29.43% | +21.41% | +8.26% | +106.64% | +1.61% | +1,097.18% | 4.15TCr | |
| -0.67% | -0.45% | -6.82% | -0.84% | +3.09% | +4.47% | +46.37% | -17.19% | +134.15% | 3.01TCr | |
| +4.77% | +6.46% | +10.66% | +58.87% | +78.28% | +41.54% | +22.78% | -55.45% | - | 2.8TCr | |
| -0.59% | -2.64% | -5.42% | +8.06% | -33.80% | -20.00% | +354.14% | +318.36% | +693.49% | 2.53TCr | |
| +0.34% | +0.28% | -2.83% | +6.11% | +3.71% | +0.12% | -12.43% | -63.83% | - | 2.48TCr | |
| +1.12% | +2.23% | +10.41% | +30.53% | +15.59% | +21.56% | -4.13% | -16.59% | +107.35% | 2.1TCr | |
| -0.06% | +1.17% | +5.11% | +17.89% | +11.17% | +21.43% | +157.40% | +229.86% | +1,990.96% | 1.74TCr | |
| +1.67% | +4.74% | -21.36% | +6.12% | +186.76% | +163.24% | +345.14% | +1,419.98% | +651.59% | 1.55TCr | |
| -1.57% | -5.02% | +3.65% | +10.00% | +20.19% | +23.36% | +40.19% | -32.19% | +85.57% | 1.5TCr | |
| +0.20% | +1.96% | -13.51% | -14.70% | - | - | - | - | - | 1.5TCr | |
| -0.03% | +8.13% | +31.36% | +42.97% | +40.25% | +2.61% | - | - | - | 1.49TCr | |
| -0.21% | +3.54% | +7.50% | +7.96% | +34.02% | +42.23% | +164.36% | +177.86% | +359.27% | 1.45TCr | |
| +2.96% | -0.65% | -5.34% | +11.80% | +24.17% | -1.74% | +535.77% | - | - | 1.44TCr | |
| +0.05% | +6.92% | +2.88% | +30.75% | +48.65% | +89.52% | +53.33% | -28.14% | +255.81% | 1.41TCr | |
| Average | +0.58% | +0.31% | +1.97% | +17.80% | +38.33% | +45.27% | +148.53% | +160.77% | +858.12% | 2.8TCr | |
| Weighted average by Cap. | +0.83% | +0.51% | +1.40% | +18.95% | +43.37% | +56.07% | +150.97% | +144.63% | +1,355.86% |
- Stock Market
- Stocks
- ATNM Stock
- Sector Actinium Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
